Defining the biosynthesis and immunological properties of complex bacterial glycolipids. We will study how sugar-lipids are made by industrially, agriculturally and medically important bacteria, and how they interact with the immune system. This will provide new insights into cell wall biosynthesis of importance to the biotechnology industry and identify new reagents for manipulating the immune system.
Modelling TRPV4 Skeletal Disorders Using Human IPSCs
Funder
National Health and Medical Research Council
Funding Amount
$1,171,187.00
Summary
Inherited skeletal disorders are a significant disease burden. Many gene mutations have been defined but we only have limited understanding about how they cause the disease. We will use patient skin cells and new in vitro re-programing technology to induce them to form cartilage cells to produce “disease in a dish” models of human skeletal disorders. These models will allow us to answer questions about how specific mutations cause disease and identify potential therapies
Metal catalysed reactions in organic synthesis. The major aim of this project is to develop highly efficient metal-catalysed routes to pharmaceuticals, e.g. new antibiotics and other commercially important organic molecules.
Particular attention will be paid to developing systems which facilitate the addition of readily available, cheap small molecules, e.g. hydrogen and carbon monoxide, to unsaturated organic molecules with high regio- and stereoselectivity.
Worldwide demand for enantiomeric ....Metal catalysed reactions in organic synthesis. The major aim of this project is to develop highly efficient metal-catalysed routes to pharmaceuticals, e.g. new antibiotics and other commercially important organic molecules.
Particular attention will be paid to developing systems which facilitate the addition of readily available, cheap small molecules, e.g. hydrogen and carbon monoxide, to unsaturated organic molecules with high regio- and stereoselectivity.
Worldwide demand for enantiomerically pure chiral molecules (i.e. one mirror-image form) continues to rise. New metal-catalysed asymmetric syntheses will help meet this challenge. Tandem metal-catalysed reactions will be used to prepare new heterocyclic compounds with potential as specific metal binding agents and biosensors.Read moreRead less
Biomimetic and Methodology Based Total Synthesis of Bioactive Natural Products. The proposal will study the synthesis of novel natural products that possess biological activities. Most significantly, this project will deliver compounds with anticancer activity. In addition, chemistry may be developed which could be utilised to synthesise a number of bioactive molecules. The rewards of the synthesis of compounds and application for the treatment of cancer and other diseases are enormous for the ....Biomimetic and Methodology Based Total Synthesis of Bioactive Natural Products. The proposal will study the synthesis of novel natural products that possess biological activities. Most significantly, this project will deliver compounds with anticancer activity. In addition, chemistry may be developed which could be utilised to synthesise a number of bioactive molecules. The rewards of the synthesis of compounds and application for the treatment of cancer and other diseases are enormous for the community and in the education and training of scientists.Read moreRead less
Total Synthesis of Novel Metabolites form Microorganisms. The main aim of this proposal is to achieve the chemical synthesis of a number of biologically active novel natural products isolated from microorganisms. This will involve the development of new methods as well as improvement on exisiting approaches developed so far. The targets will include the myxobacteria metabolites crocacins A, B and D and apicularen A, the streptomyces metabolites reveromycin A and spirofungin A and the fungal meta ....Total Synthesis of Novel Metabolites form Microorganisms. The main aim of this proposal is to achieve the chemical synthesis of a number of biologically active novel natural products isolated from microorganisms. This will involve the development of new methods as well as improvement on exisiting approaches developed so far. The targets will include the myxobacteria metabolites crocacins A, B and D and apicularen A, the streptomyces metabolites reveromycin A and spirofungin A and the fungal metabolite zaragozic acid C.
Read moreRead less
Synthesis of Bioactive Metabolites from Myxobacteria. The crocacins and apicularens are two diverse groups of biologically active molecules isolated from myxobacteria. Crocacins A-D are dipeptides which show antifungal activity and are highly cytostatic in mammalian cell cultures. The novel macrolide apicularen A is highly active against a number of human tumour cell lines and shows promise as a new type of anticancer compound. The aim of this project is develop a methodology to synthesise these ....Synthesis of Bioactive Metabolites from Myxobacteria. The crocacins and apicularens are two diverse groups of biologically active molecules isolated from myxobacteria. Crocacins A-D are dipeptides which show antifungal activity and are highly cytostatic in mammalian cell cultures. The novel macrolide apicularen A is highly active against a number of human tumour cell lines and shows promise as a new type of anticancer compound. The aim of this project is develop a methodology to synthesise these novel compounds.Read moreRead less
Functional polymeric nanopores from cyclic peptide templates. This research programme will develop nanotubes prepared through the self-assembly of cyclic peptide/polymer conjugates into functional devices for applications as nanopores. The project will establish the fundamental knowledge required to develop these materials into nanoporous polymeric films and transmembrane channels. The research programme will establish new synthetic routes to the conjugates, ascertain the technique of assembly i ....Functional polymeric nanopores from cyclic peptide templates. This research programme will develop nanotubes prepared through the self-assembly of cyclic peptide/polymer conjugates into functional devices for applications as nanopores. The project will establish the fundamental knowledge required to develop these materials into nanoporous polymeric films and transmembrane channels. The research programme will establish new synthetic routes to the conjugates, ascertain the technique of assembly into nanotubes, with a particular focus on improving the precision with which we achieve structural control, and explore the use of the nanotubes to design nanopores, for applications in the manufacture of nanoporous materials, as antibiotic agents and as biosensors.Read moreRead less
Improving Muscular Dystrophy By Targeting The ADAMTS5 Metalloproteinase
Funder
National Health and Medical Research Council
Funding Amount
$658,571.00
Summary
Muscular dystrophy is a devastating childhood disorder. There is no cure and no effective therapy to stop the disease progressing to early death. Our pilot data show that muscular dystrophy in a mouse model is dramatically improved when the Adamts5 gene is inactivated. ADAMTS5 is an enzyme that remodels the extracellular matrix around cells. This suggests that inhibiting ADAMTS5 may be a new way to treat muscular dystrophy. We will test this idea in mice with muscular dystrophy
AI Assisted Continuous Flow Electrochemistry for Pharmaceutical Manufacture. This project aims to develop new chemical manufacturing processes for pharmaceutical products. In collaboration with Sun Pharma, it will tackle the challenge of replacing expensive and toxic chemicals in industrial reactions, to lower cost of manufacturing and improve its sustainability profile. Central to the realisation of this ambition is the use of electrocatalysis, machine learning and implementation of advanced co ....AI Assisted Continuous Flow Electrochemistry for Pharmaceutical Manufacture. This project aims to develop new chemical manufacturing processes for pharmaceutical products. In collaboration with Sun Pharma, it will tackle the challenge of replacing expensive and toxic chemicals in industrial reactions, to lower cost of manufacturing and improve its sustainability profile. Central to the realisation of this ambition is the use of electrocatalysis, machine learning and implementation of advanced continuous flow methods. These electricity- and technology-driven reactions will develop new strategies for the generation of important classes of molecules relevant to the Australia’s pharmaceutical sector, as well as their manufacture at industrially relevant scales.Read moreRead less
Epilepsy is one of the most common chronic neurological disorders; it affects 1% of the world’s population, yet about 1 in 3 patients fail to achieve seizure control with current drugs. We will improve the properties of small molecules (drugs) that specifically target the GTPase activity of the enzyme dynamin, to reduce seizure effect in the brain by a novel mechanism. We will optimize and pre-clinically test these future chemical entities as potential anti-epileptic drugs.